Search Reports


Healthcare » Biotechnology »

Regenerative Medicine Market, Size, Share, Outlook and Growth Opportunities 2019-2025

  • ID:OGAHM1960491
  • Published: June-2019
  • Pages:130
  • OGAnalysis
1 of 3

Global Regenerative Medicine Market Outlook and Growth Opportunities to 2025: By Therapy (Cell Therapy, Gene Therapy, and Tissue Engineering), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other applications) and By Region

Key Findings:

  • Tissue engineering is the largest segment with a market share of 63% in 2018        
  • As of 2018, the total clinical trials underway in the global regenerative medicine were 1003 with major clinical trials being in Phase II (580).
  • Gene therapy segment is leading the regenerative medicine market share with a revenue base of USD 3,924.61 million.
  • The U.S leads regenerative medicine market accounts for 40% of global share for cell therapy.

Global regenerative medicine market growth is expected to have a positive impact over the upcoming period due to increasing number of companies operating in the regenerative medicine, rising occurrences of trauma emergencies, along with various developments in surgical technologies and monitoring devices.

In Addition, deficiency of organs for transplantation, and growing adoption of gene therapies are the major driving factors in the growth of global regenerative medicine market.

Continuous investments by government and private agencies to support R&D also accelerate the growth of regenerative medicine market. For instance, the National Institutes of Health (NIH) supports scientific research community through NIH Regenerative Medicine Program, NIH Stem Cell Libraries & Projects, NIH Stem Cell Unit, and others.

Rising prevalence of chronic diseases, increasing funding from government and private companies, strategic partnerships and focus on cell therapy products are the key factors boosting the market growth.

Global regenerative medicines market Insights

The 2019 series of global regenerative medicines market size, share, trends, outlook and growth prospects is a comprehensive analysis on global regenerative medicines market conditions. The major trends shaping the near and long term future of the industry, drivers, opportunities and restraints of regenerative medicines market, detailed porter’s five forces analysis and competitive insights are included in the research.

Global regenerative medicines market size by therapy

The report provides the detailed annual outlook of each therapy of the regenerative medicines market to 2025. Cell therapy, Gene therapy, and Tissue engineering are included in the regenerative medicines market report. Among these tissue engineering is the dominant segment, which occupies a major share in the global industry.

Global regenerative medicines market share by applications

The report presents the detailed outlook of applications of regenerative medicines market to 2025. Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other applications are included in the regenerative medicines market report. Among these, Musculoskeletal Disorders is the largest segment that occupies a major share in global industry.

Global regenerative medicines e market revenue by region

The current regenerative medicines market size in terms of revenue across 5 regions including North America, Europe, Asia Pacific, South & Central America and Middle East & Africa are studied in the report. Globally, North America is the major revenue contributor to the global market.

Global regenerative medicines market analysis by Company

Top 10 leading companies in global regenerative medicines market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and regenerative medicines products and services.

Global regenerative medicines market news and recent developments

Latest news and industry developments in terms of adhesive capacity expansions, acquisitions, organic and inorganic growth strategies, joint ventures and collaborations, product launches, market expansions etc are included in the report.

Scope

Long term perspective on the Regenerative Medicine industry: 2018 (base year), 2019- 2025 (forecast period)

Regenerative Medicine Market- Forecasts by Segments- Therapy, and Application by geography.

  1. The report provides the Regenerative Medicine market outlook by 3 therapies including Cell Therapy, Gene Therapy, and Tissue Engineering.
  2. It provides the market outlook by 6 applications including Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other applications.
  3. Regenerative Medicine market across countries in 5 regions including North America, Europe, Asia-Pacific, South & Central America and Middle East & Africa are covered.

Regenerative Medicine Market- Strategic Analysis Review

  1. Key strategies opted by leading players
  2. Short to Long Term Industry Trends
  3. Porter’s Five Forces Analysis
  4. Supply side and Demand Side Drivers and Challenges

Regenerative Medicine Market- Growth Opportunities

  1. Potential New Business Opportunities
  2. Key Areas of Focus in forecast period

Regenerative Medicine Market- Competitive Scenario

  1. 10 companies are analysed in the report including Novartis AG, Vericel, Integra Life sciences, Mimedx Group, Stryker, Wright Medical, Spark Therapeutics, Osiris Therapeutics, Kite Pharma (Subsidiary of Gilead Sciences), Organogenesis.
  2. Company Peer-to-Peer Comparison
  3. Company Profile and SWOT Analysis
  4. Financial Analysis

1 of 3

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Introduction to Global Regenerative Medicine Market
2.1 Global Regenerative Medicine Market Snapshot, 2018
2.2 Regenerative Medicine Industry Overview
2.3 Research Perspective
3. Global Regenerative Medicine Market- Strategic Analysis
3.1 Short Term and Long Term Industry Trends Affecting Global Regenerative Medicine Market
3.2 Leading Regenerative Medicine Types Targeted by Global Manufacturers
3.3 Key Consumption Patterns of Regenerative Medicine
3.4 Potential Markets Vital for business Expansion
3.5 Five Forces Analysis
3.6 Drivers and Restraints
4. Global Regenerative Medicine Market Outlook and Growth Opportunities by Therapy
4.1 Cell Therapy Regenerative Medicine Market Outlook, 2019- 2025
4.2 Gene Therapy Regenerative Medicine Market Outlook, 2019- 2025
4.3 Tissue Engineering Regenerative Medicine Market Outlook, 2019- 2025
5. Global Regenerative Medicine Market Outlook and Growth Opportunities by Application
5.1 Regenerative Medicine Demand in Musculoskeletal Disorders, Market Outlook, 2019- 2025
5.2 Regenerative Medicine Demand in Wound Care, Market Outlook, 2019- 2025
5.3 Regenerative Medicine Demand in Oncology, Market Outlook, 2019- 2025
5.4 Regenerative Medicine Demand in Ocular Disorders, Market Outlook, 2019- 2025
5.5 Regenerative Medicine Demand in Diabetes, Market Outlook, 2019- 2025
5.6 Regenerative Medicine Demand in Other applications, Market Outlook, 2019- 2025
6. Asia Pacific Regenerative Medicine Market Outlook and Growth Opportunities
6.1 Key Findings, 2018
6.2 Asia Pacific Regenerative Medicine Market Outlook by Therapy, 2019- 2025
6.3 Asia Pacific Regenerative Medicine Market Outlook by Application, 2019- 2025
6.4 Asia Pacific Regenerative Medicine Market Outlook by Country, 2019- 2025
7. Europe Regenerative Medicine Market Outlook and Growth Opportunities
7.1 Key Findings, 2018
7.2 Europe Regenerative Medicine Market Outlook by Therapy, 2019- 2025
7.3 Europe Regenerative Medicine Market Outlook by Application, 2019- 2025
7.4 Europe Regenerative Medicine Market Outlook by Country, 2019- 2025
8. North America Regenerative Medicine Market Outlook and Growth Opportunities
8.1 Key Findings, 2018
8.2 North America Regenerative Medicine Market Outlook by Therapy, 2019- 2025
8.3 North America Regenerative Medicine Market Outlook by Application, 2019- 2025
8.4 North America Regenerative Medicine Market Outlook by Country, 2019- 2025
9. South & Central America Regenerative Medicine Market Outlook and Growth Opportunities
9.1 Key Findings, 2018
9.2 South & Central America Regenerative Medicine Market Outlook by Therapy, 2019- 2025
9.3 South & Central America Regenerative Medicine Market Outlook by Application, 2019- 2025
9.4 South & Central America Regenerative Medicine Market Outlook by Country, 2019- 2025
10. Middle East & Africa Regenerative Medicine Market Outlook and Growth Opportunities
10.1 Key Findings, 2018
10.2 Middle East & Africa Regenerative Medicine Market Outlook by Therapy, 2019- 2025
10.3 Middle East & Africa Regenerative Medicine Market Outlook by Application, 2019- 2025
10.4 Middle East & Africa Regenerative Medicine Market Outlook by Country, 2019- 2025
11. Competitive Landscape
11.1 Leading Players (Company Profile, SWOT Analysis, Regenerative Medicine Products, Financial Analysis)
11.1.1 Novartis AG
11.1.2 Vericel
11.1.3 Integra Life sciences
11.1.4 Mimedx Group
11.1.5 Hexcel Corporation
11.1.6 Stryker
11.1.7 Wright Medical
11.1.8 Spark Therapeutics
11.1.9 Organogenesis
11.1.10 Kite Pharma
11.2 Company Benchmarking
11.3 Financial Analysis
12. Recent News and Deals Landscape
12.1 Mergers and Acquisitions
12.2 New Product Launches
12.3 Asset Transactions
12.4 Financial Announcements
13. Appendix
13.1 OG Analysis Expertise
13.2 Sources and Research Methodology
13.3 Contact Information



1 of 3

Type Delivery Format Details
Hard Copy A printed copy of the report will be shipped to you.
CD-ROM The report will be shipped to you in CD ROM format.
SINGLE USER Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows one specific user access to the product.
SITE LICENSE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all users within a given geographical location of your organization access to the product.
ENTERPRISEWIDE Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows all employees within your organization in different geographic locations access to the product.
1 - 5 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to five users have access to the product.
1 – 10 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to ten users have access to the product.
1 – 15 USERS Electronic (PDF) The report will be delivered to your email address in PDF format. The license allows up to fifteen users have access to the product.
1 - 5 USERS Online Access (For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to five users have access to the product.
1 - 10 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to ten users have access to the product.
1 - 15 USERS Online Access(For Databases) Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. The license allows up to fifteen users have access to the product.
1 - 5 USERS Electronic (Excel) The Excel spreadsheet will be emailed to you. The license allows up to five users have access to the product.


PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-10 user licence, allowing up to ten users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-15 user licence, allowing up to fifteen users have access to the product.